Smith J H F
Department of Histopathology, Royal Hallamshire Hospital, Sheffield, UK.
Cytopathology. 2002 Feb;13(1):4-10. doi: 10.1046/j.1365-2303.2002.00397.x.
The Bethesda system (TBS) for reporting cervical/vaginal cytological diagnoses was originally developed in 1988 at a National Cancer Institute (NCI) workshop convened to consider the benefits of increased standardization in the diagnostic reports provided by cytology laboratories. It rapidly gained acceptance in laboratory practice in the USA and beyond and three years later the NCI sponsored another workshop to assess the use of TBS in practice and consider areas for improvement. Subsequently an illustrated guide was published.
用于报告宫颈/阴道细胞学诊断的贝塞斯达系统(TBS)最初于1988年在美国国立癌症研究所(NCI)举办的一次研讨会上开发,该研讨会旨在探讨提高细胞学实验室诊断报告标准化带来的益处。它很快在美国及其他地区的实验室实践中得到认可,三年后,NCI主办了另一次研讨会,以评估TBS在实际中的应用情况并考虑改进领域。随后出版了一本图文并茂的指南。